📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sunshine Biopharma

1.1 - Company Overview

Sunshine Biopharma Logo

Sunshine Biopharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of research, development, and commercialization of drugs for the treatment of various forms of cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sunshine Biopharma

Ness Therapeutics Logo

Ness Therapeutics

HQ: Canada Website
  • Description: Provider of biotechnology aimed at preventing respiratory viruses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ness Therapeutics company profile →
Iomai Logo

Iomai

HQ: United States Website
  • Description: Provider of vaccines and immune system stimulants delivered via transcutaneous immunization (TCI), a novel needle-free technology that taps antigen-presenting cells in the outer layers of the skin to generate an enhanced immune response.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iomai company profile →
Ciclofilin Pharmaceuticals Logo

Ciclofilin Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development focused on cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and degenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ciclofilin Pharmaceuticals company profile →
RPS Diagnostics Logo

RPS Diagnostics

HQ: United States Website
  • Description: Provider of rapid point-of-care (POC) screening to identify patients with infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RPS Diagnostics company profile →
Armata Pharmaceuticals Logo

Armata Pharmaceuticals

HQ: United States Website
  • Description: Provider of bacteriophage-based therapeutics, including AP-PA02 for Pseudomonas aeruginosa respiratory infections, AP-SA02 for drug-resistant Staphylococcus aureus (MRSA/VRSA), and AP-PA03 for P. aeruginosa pneumonia, plus a proprietary synthetic phage engineering platform, phage discovery and phenotyping, and bioinformatics-enabled phage analyses to enhance efficacy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Armata Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sunshine Biopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sunshine Biopharma

2.2 - Growth funds investing in similar companies to Sunshine Biopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sunshine Biopharma

4.2 - Public trading comparable groups for Sunshine Biopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sunshine Biopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sunshine Biopharma

What does Sunshine Biopharma do?

Sunshine Biopharma is a provider of research, development, and commercialization of drugs for the treatment of various forms of cancer.

Who are Sunshine Biopharma's competitors?

Sunshine Biopharma's competitors and similar companies include Ness Therapeutics, Iomai, Ciclofilin Pharmaceuticals, RPS Diagnostics, and Armata Pharmaceuticals.

Where is Sunshine Biopharma headquartered?

Sunshine Biopharma is headquartered in United States.

How many employees does Sunshine Biopharma have?

Sunshine Biopharma has 1,000 employees 🔒.

When was Sunshine Biopharma founded?

Sunshine Biopharma was founded in 2010 🔒.

What sector and industry vertical is Sunshine Biopharma in?

Sunshine Biopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sunshine Biopharma

Who are the top strategic acquirers in Sunshine Biopharma's sector and industry

Top strategic M&A buyers and acquirers in Sunshine Biopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sunshine Biopharma?

Top strategic M&A buyers groups and sectors for Sunshine Biopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sunshine Biopharma's sector and industry vertical

Which are the top PE firms investing in Sunshine Biopharma's sector and industry vertical?

Top PE firms investing in Sunshine Biopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sunshine Biopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sunshine Biopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sunshine Biopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sunshine Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sunshine Biopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sunshine Biopharma?

The key public trading comparables and valuation benchmarks for Sunshine Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sunshine Biopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sunshine Biopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sunshine Biopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sunshine Biopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sunshine Biopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Sunshine Biopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sunshine Biopharma